BDBM50204598 CHEMBL3933723::US10285989, Example 88

SMILES CC[C@@H](NC(=O)c1cc(=O)[nH]c(n1)N(C)C)c1ccc(SC(F)(F)F)cc1

InChI Key InChIKey=GEDIOFTUVMVVFP-UHFFFAOYSA-N

Data  5 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 50204598   

TargetPhosphodiesterase(Rhesus macaque)
Therachem Research Medilab (India)

Curated by ChEMBL
LigandPNGBDBM50204598(CHEMBL3933723 | US10285989, Example 88)
Affinity DataKi:  0.510nMAssay Description:Inhibition of rhesus monkey PDE2A3 expressed in AD293 cells using FAM-labeled cAMP as substrate after 60 mins in presence of cGMP by florescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2018
Entry Details Article
PubMed
TargetPhosphodiesterase(Rhesus macaque)
Therachem Research Medilab (India)

Curated by ChEMBL
LigandPNGBDBM50204598(CHEMBL3933723 | US10285989, Example 88)
Affinity DataKi:  0.510nMAssay Description:The activity of the compounds in accordance with the present invention as PDE2 inhibitors may be readily determined using a fluorescence polarization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetPhosphodiesterase(Rhesus macaque)
Therachem Research Medilab (India)

Curated by ChEMBL
LigandPNGBDBM50204598(CHEMBL3933723 | US10285989, Example 88)
Affinity DataKi:  0.610nMAssay Description:The activity of the compounds in accordance with the present invention as PDE2 inhibitors may be readily determined using a fluorescence polarization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetcGMP-dependent 3',5'-cyclic phosphodiesterase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50204598(CHEMBL3933723 | US10285989, Example 88)
Affinity DataKi:  0.690nMAssay Description:The activity of the compounds in accordance with the present invention as PDE2 inhibitors may be readily determined using a fluorescence polarization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetcGMP-dependent 3',5'-cyclic phosphodiesterase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50204598(CHEMBL3933723 | US10285989, Example 88)
Affinity DataKi:  5.05nMAssay Description:The activity of the compounds in accordance with the present invention as PDE2 inhibitors may be readily determined using a fluorescence polarization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent